Short title
Short title. This Act may be cited as the Clinical Trial Participation Program Act. (Source: P.A. 103-227, eff. 6-30-23.)
Illinois · statute · 410 ILCS 416 · 9 active provisions
Short title. This Act may be cited as the Clinical Trial Participation Program Act. (Source: P.A. 103-227, eff. 6-30-23.)
Findings. The General Assembly finds that: (1) The ability to translate medical findings from research to practice relies largely on robust subject participation and a diverse subject participation pool in clinical trials. (2) Diverse subject participation in clinical trials depends significantly on whether an individu…
Definitions. In this Act: "Clinical trial" means (i) a research study that subjects an individual to a new cancer treatment, including a medication, chemotherapy, adult stem cell therapy, or other treatment or (ii) a voluntary research study conducted on people and designed to answer specific questions about the safety…
Establishment. An independent third-party organization may develop and implement the clinical trial participation program to provide reimbursement to subjects for ancillary costs associated with participation in a clinical trial, including costs for: (1) travel; (2) lodging; (3) parking and tolls; and (4) other related…
Requirements; notice. (a) The program: (1) must collaborate with physicians, health care providers, and clinical trial sponsors to notify a prospective subject about the program when: (A) the prospective subject consents to a clinical trial; or (B) funding is available to provide the program for the clinical trial in w…
Reimbursement requirements; notice. (a) A reimbursement under the program at a trial site that conducts clinical trials must: (1) be reviewed and approved by the institutional review board associated with the clinical trial for which the reimbursement is provided; and (2) comply with applicable federal and State laws.…
Reimbursement status as undue inducement. Reimbursement of ancillary costs incurred by a subject under the program: (1) does not constitute an undue inducement to participate in a clinical trial; (2) is not considered coercion or the exertion of undue influence to participate in a clinical trial; and (3) shall be deeme…
Funding. The independent third-party organization that administers the program may accept gifts, grants, and donations from any public or private source to implement this Act. (Source: P.A. 101-619, eff. 12-20-19.)
Effective date. This Act takes effect upon becoming law. (Source: P.A. 101-619, eff. 12-20-19.)